NCT03062592View on ClinicalTrials.gov

FFAR Agonist on Incretins, Insulin, Lipids and Inflammation

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Type2 Diabetes MellitusObesity
Interventions
DIETARY_SUPPLEMENT

Pine nut oil

Subjects are supplemented with either no oil, hydrolyzed oil or non-hydrolyzed oil in combination with an OGTT

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT03062592 - FFAR Agonist on Incretins, Insulin, Lipids and Inflammation | Biotech Hunter | Biotech Hunter